Expression and DNA microarray analysis of a platelet activating factor-related molecule in severe pneumonia in mice

Masafumi Seki1, Kosuke Kosai, Atsuko Hara

  • 1Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501, Japan. seki@nagasaki-u.ac.jp

Insights

Co-infection with influenza virus and Streptococcus pneumoniae significantly increases platelet-activating factor (PAF) and its receptor (PAFR) in mouse lungs, indicating their role in severe pneumonia.

Area of Science:

  • Immunology
  • Microbiology
  • Pulmonary Medicine

Background:

  • Platelet-activating factor (PAF) is a key mediator in severe inflammatory conditions like pneumonia.
  • The PAF receptor (PAFR) facilitates Streptococcus pneumoniae attachment to lung cells.
  • Influenza virus and S. pneumoniae co-infection can lead to severe pneumonia.

Purpose of the Study:

  • To identify critical factors involved in fulminant pneumonia caused by influenza virus and S. pneumoniae co-infection.
  • To investigate the role of PAF and related molecules in this co-infection model.

Main Methods:

  • DNA microarray analysis in a mouse model of co-infection.
  • Measurement of PAF-acetyl hydrolase (PAF-AH) levels and enzymatic activity.
  • Assessment of PAFR expression in lung tissue.

Main Results:

  • Co-infected mouse lungs showed significantly increased PAF-AH levels and PAFR expression compared to single infections.
  • Elevated PAF-AH enzymatic activity was observed in co-infected lungs.
  • These findings suggest activation of PAF-related pathways during co-infection.

Conclusions:

  • PAF and associated molecules are crucial in severe pneumonia resulting from influenza virus and S. pneumoniae co-infection.
  • The study highlights the complex inflammatory response during polymicrobial respiratory infections.

Related Concept Videos